AfroCentric Group’s Post

South Africa is rolling out Lenacapavir, a long-acting injectable PrEP announced by Deputy Minister of Health, Dr Joe Phaahla, at the 12th SA National AIDS Conference. Supported by R520 million from The Global Fund, this twice-yearly injection could reshape HIV prevention for key populations. Aid for Aids (AfA), a subsidiary of AfroCentric Group, recently showed support for the move - calling it a ray of sunshine amid recent funding cuts from USAID and PEPFAR. AfA also highlighted the need for strong public-private partnerships to ensure Lenacapavir gets the support it deserves. “The future is not distant. We are building it now, for mothers, fathers, children and generations to come. Together, we will end Aids, eliminate its co-travellers and write a new chapter of health equity in South Africa,” – says Dr Phaahla. Read more to find out how this anti-HIV injection may redefine SA’s public health response: https://shorturl.at/dj7IO #Lenacapavir #HIVPrevention #EndAIDS #PrEP #PublicHealth